Artiva Biotherapeutics, Inc. Common Stock (ARTV)

9.97

(-9.69%)

Long Term Debt Summary of Artiva Biotherapeutics, Inc. Common Stock

  • Artiva Biotherapeutics, Inc. Common Stock's latest annual long term debt in 2023 was 13.31 Million USD , down -16.58% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock's latest quarterly long term debt in 2024 Q2 was 11.97 Million USD , down 0.0% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported annual long term debt of 15.96 Million USD in 2022, up 1120.34% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported annual long term debt of 1.3 Million USD in 2021, down -21.11% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported quarterly long term debt of 12.61 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported quarterly long term debt of 13.31 Million USD for 2023 FY, down -16.58% from previous quarter.

Annual Long Term Debt Chart of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2019)

Historical Annual Long Term Debt of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 13.31 Million USD -16.58%
2022 15.96 Million USD 1120.34%
2021 1.3 Million USD -21.11%
2020 1.65 Million USD 0.0%
2019 - USD 0.0%

Peer Long Term Debt Comparison of Artiva Biotherapeutics, Inc. Common Stock

Name Long Term Debt Long Term Debt Difference